by Mejbel Alazemi | Nov 5, 2026 | Commentary, Featured, Grand Round Summaries, Patient Advocacy
Emergency medicine is defined by uncertainty. But when uncertainty becomes a reflex to test, test, and test again, we may be doing more harm than good with low value testing. I want to tell you about two emergency physicians. Same hospital. Same patient: a...
by Talal Alkhaldi | Oct 29, 2026 | Cardiology, Critical Care, Featured, Grand Round Summaries, Resuscitation, Surgery, Trauma
It is three in the morning. A 58-year-old man with hypertension walks in with sudden, severe chest pain. He looks uncomfortable but stable. His ECG is normal. His troponin is pending. And somewhere in the back of your mind, a quiet voice says: could this be a...
by Thariq Badiudeen, Nathan Hecht | Oct 8, 2026 | Featured, OBGYN, Ultrasound
It’s 2:30 AM. A 29-year-old woman presents ten days after a medical abortion. She’s febrile, tachycardic, and complaining of worsening pelvic pain. She has a small amount of vaginal bleeding, and her abdomen is soft. Her β-hCG is still positive, which is...
by Naman Arora | Oct 1, 2026 | Critical Care, Featured, Grand Round Summaries, Infectious Disease, Resuscitation
Sepsis resuscitation has evolved considerably over the past two decades, moving away from rigid protocols toward more individualized care. Yet many familiar targets remain: 30 mL/kg of fluid, a MAP of 65, and lactate clearance. But not every patient benefits from more...
by Caroline Gregory | Sep 30, 2026 | Journal Club, Thrombosis
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism (Therapy) Castellucci LA, et al. N Engl J Med. 2026 Mar 12;394(11):1051-1060. doi: 10.1056/NEJMoa2510703. Editorial: Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous...
